Tag : autoimmune and inflammatory diseases

Healthcare Quality, Patient Safety & Policy

Boehringer Ingelheim, Cue Biopharma Partner on Autoimmune Therapies

GlobeNewswire
Boehringer Ingelheim and Cue Biopharma, Inc. (Nasdaq: CUE) today announced a strategic research collaboration and license agreement to develop and commercialize Cue Biopharma’s CUE-501 product candidate, a...